Management
Study Director
Dr Cheung-Tak Hung (PhD, MRPharmS)
Dr Cheung-Tak Hung has been an Executive Director of ZenTech since 1988. Dr Hung was a Senior Lecturer in Pharmacy, University of Otago, NZ (1983-1988). Dr Hung received his B.Sc. (Hons) degree in Pharmacy in 1978 and Ph.D. in Pharmaceutical Science in 1982 from Aberdeen, UK.
Dr Hung's research interests include drug targeting, pharmaceutics, pharmaceutical formulation and pharmaceutical analysis. Dr Hung has published some 90 original articles in scientific and medical journals and is the inventor of two patents.
Dr Hung jointly received the Distinguished Biotechnologist Award for 2002.
Departmental Heads
Administration
Ms Linda Folland (CA, BCom)
The Company Administration Manager is Linda Folland. Linda has been with ZenTech since 1992 and holds a central position in the company's financial affairs. Linda is also the Co-Ordinator of the Company's Independent Ethics Committee through which approval of all bioequivalence studies undertaken by ZenTech is obtained. In addition Linda also liaises with the Health Research Council to ensure the Ethics Committee operate within its regulations and guidelines in order to maintain accreditation.
Laboratory
Mr David Ren (BSc)
David joined ZenTech in 2001 as the Quality Manager and maintained the Biopharmaceutical quality system to the standard required to retain ISO9002 accreditation (which was acquired in 1999). David now oversees the day to day management of the laboratory.
Clinical Investigator
Dr Noelyn Hung (BSc, MBChB, FRCPA)
Dr Noelyn Hung has been with ZenTech since 1989. Noelyn is responsible for the development, implementation and medical monitoring of the Bioavailability Studies as well as for overseeing Trial Physicians.
Dr James Ng (MBChB, MBE)
Quality & Statistics
Dr Fred Lam (PhD)
Dr Fred Lam has been providing statistical advises to ZenTech since 1988. He joined ZenTech in 2006 as Chief Statistician. He is now also the Quality Manager. Fred is responsible for improving and maintaining the ZenTech quality system. He is also responsible for the development and implemetation of the statistical design and analysis of the Bioequivalence Studies.
Consultant Anaesthesiologist
Dr Evered Strauss (MB ChB (Pret), DA (SA) FFA (SA) Wits, FANZCA)
Dr Evered Strauss has been employed as a Consultant Anaesthesiologist since 2003. Evered is responsible for the well-being of participants during studies which require consultation from a intensive care specialist.